Published in Semin Thromb Hemost on January 01, 1995
A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell (1985) 16.46
Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol (1968) 4.22
An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences. Cell (1984) 3.61
Treatment of older patients with mantle-cell lymphoma. N Engl J Med (2012) 3.46
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. Proc Natl Acad Sci U S A (1985) 2.74
Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci U S A (2001) 2.63
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med (1991) 2.40
CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial. Neurology (2001) 2.16
High frequency of homologous recombination in mammalian cells between endogenous and introduced SV40 genomes. Cell (1985) 2.14
[Guideline-conforming interventional treatment of acute ST-segment elevation myocardial infarction in rural areas using network collaboration]. Dtsch Med Wochenschr (2004) 2.11
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
Repaglinide in the management of new-onset diabetes mellitus after renal transplantation. Am J Transplant (2006) 2.01
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood (1994) 1.95
Organic cation transport in the rat kidney in vivo visualized by time-resolved two-photon microscopy. Kidney Int (2007) 1.68
Simian virus 40 enhancer increases RNA polymerase density within the linked gene. Nature (1985) 1.66
Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome. Leukemia (2004) 1.64
Studies on lysosomes. XII. Redistribution of acid hydrolases in human lymphocytes stimulated by phytohemagglutinin. J Cell Biol (1968) 1.58
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill (2013) 1.55
Enhancer activity correlates with the oncogenic potential of avian retroviruses. EMBO J (1985) 1.52
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. Eur J Neurol (2012) 1.51
Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. Clin Nephrol (2006) 1.50
Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells. Ann Neurol (1995) 1.50
Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J (1986) 1.48
Serum cystatin C--a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine. Clin Nephrol (2005) 1.43
Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Kidney Int (2000) 1.40
The impact of television on attitudes towards organ donation--a survey in a German urban population sample. Nephrol Dial Transplant (1999) 1.40
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
Recurrent neurovascular hypertension: MR findings before and after surgical treatments. AJNR Am J Neuroradiol (2001) 1.39
[Magnetic resonance imaging of tibial periostitis]. J Radiol (1998) 1.38
Transfer RNAs of potato (Solanum tuberosum) mitochondria have different genetic origins. Nucleic Acids Res (1990) 1.33
Mechanism of chaperonin action: GroES binding and release can drive GroEL-mediated protein folding in the absence of ATP hydrolysis. EMBO J (1996) 1.32
Template activity of nuclei from stimulated lymphocytes. Nature (1969) 1.31
[A case of Goldenhar syndrome: acute vitamin A intoxication in the mother during pregnancy]. J Genet Hum (1975) 1.31
Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant (1998) 1.29
Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest (1993) 1.27
Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. J Immunol (1989) 1.26
Identification of 21r and 22r chromosomes by quinacrine fluorescence. Clin Genet (1972) 1.25
Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler (2004) 1.24
Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann Oncol (1995) 1.24
Redundancy of information in enhancers as a principle of mammalian transcription control. J Mol Biol (1988) 1.23
Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet (1978) 1.21
Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury : possible connection to an interleukin-6-dependent pathway. Am J Pathol (2000) 1.21
Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.19
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol (1984) 1.17
Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol (2000) 1.17
Association between transplantation antigens and a viral membrane protein synthesized from a mammalian expression vector. Cell (1983) 1.16
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma. J Clin Oncol (1998) 1.15
Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis. Ann Hematol (1998) 1.15
Interhospital transportation of patients with severe lung failure on pumpless extracorporeal lung assist. Br J Anaesth (2005) 1.14
Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol (2000) 1.13
5-Fluorouracil induces arterial vasocontractions. Ann Oncol (2004) 1.13
A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther (1999) 1.12
Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem (1995) 1.12
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci Lett (1996) 1.11
Letter: Decrease of T lymphocytes during ageing. Lancet (1974) 1.11
Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Hum Hypertens (2003) 1.11
The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol. Life Sci (1981) 1.09
Lymphocyte lysosomes and lysosomal enzymes in chronic lymphocytic leukemia. Blood (1973) 1.08
Rearranged antigen receptor genes in Hodgkin's disease. Blood (1987) 1.07
Molecular genetics and the diagnosis of lymphoma. Arch Pathol Lab Med (1988) 1.05
Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol (2002) 1.04
Glutathione reductase test with whole blood, a convenient procedure for the assessment of the riboflavin status in humans. Experientia (1974) 1.04
Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension. J Am Coll Cardiol (2001) 1.03
Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol (2007) 1.03
The fourth genus in the Orthomyxoviridae: sequence analyses of two Thogoto virus polymerase proteins and comparison with influenza viruses. Virus Res (1997) 1.03
Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. Leukemia (1997) 1.02
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med (1992) 1.02
CDI Blood Parameter Monitoring System 500--a new tool for the clinical perfusionist. J Extra Corpor Technol (2000) 1.01
Duplication 11 (q21 to 23 leads to qter) syndrome. Birth Defects Orig Artic Ser (1977) 1.01
Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline. Klin Wochenschr (1987) 1.00
Why not adhere to the original Kiel classification? Lancet (1980) 1.00
Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol (2001) 1.00
A transcription enhancer in the Herpesvirus saimiri genome. EMBO J (1985) 0.99
Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int (1999) 0.99
[Pumpless extracorporeal lung assist using arterio-venous shunt in severe ARDS. Experience with 30 cases]. Anaesthesist (2004) 0.98
Patient restraint and safety vests: minimizing the hazards. Dimens Health Serv (1981) 0.97
The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology (1995) 0.97
Do urinary tract infections trigger chronic kidney transplant rejection in man? J Urol (1998) 0.97
Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.96
CT and MR imaging in neuro-Behçet disease. J Comput Assist Tomogr (1986) 0.96
Endothelin in cardiovascular control: the role of endothelin antagonists. Curr Hypertens Rep (2001) 0.96
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. J Neuroimmunol (2002) 0.95
Rosette-forming lymphocytes in Hodgkin's disease. N Engl J Med (1973) 0.95
An ultrasonographic study of the organisation of sucking and swallowing by newborn infants. Dev Med Child Neurol (1986) 0.95
Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man. Br J Clin Pharmacol (2001) 0.95
Identification of copy number variants in miscarriages from couples with idiopathic recurrent pregnancy loss. Hum Reprod (2010) 0.95
Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone. Eur J Immunol (1993) 0.95
Evaluation of organ donor card holders among public officials of a major German city. Transplant Proc (2009) 0.94
Limited diversity and selection of rearranged gamma genes in polyclonal T cells. J Immunol (1987) 0.94
Antigenic phenotyping of human follicular dendritic cells isolated from nonmalignant and malignant lymphatic tissue. Eur J Immunol (1990) 0.94
Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant (2001) 0.94